The Analytical Core is a central resource designed to facilitate the development and application of powerful analytical methods to solve key problems encountered by the components of the Superfund Project. The general goals of the Analytical Core are to facilitate research and develop analytical technologies that address the detection, assessment, evaluation and reduction of hazardous chemical exposure and the associated population health risks. There are three specific aims proposed by the Analytical Core: 1) Provide analytical support for projects in the Superfund Program using chromatographic and spectroscopic techniques. 2) Provide high sensitivity analysis of hazardous substances using Accelerator Mass Spectroscopy (AMS) and Nuclear Microscopy. 3) Provide support in peptide chemistry including gas phase sequencing and LC-MS analysis of peptides. Accomplishment of Aim 1 will include enhanced development of phase sequencing of chemical exposure through application of immunoaffinity purification and development of HPLC/MS/MS biomarkers of chemical exposure through application of immunoaffinity purification and development of HPLC/MS/MS driven multi-dimensional metabolite profiling. Support will also be provided by for toxic substances identification from complex mixtures by performing fractionation and structural elucidation duties in multi-project toxicity identification complex mixtures by performing fractionation and structural elucidation duties in multi-project toxicity identification evaluation studies (TIEs). The Analytical Core will develop vacuum ultraviolet ionization mass spectroscopy instrumentation for the sensitive detection and quantitation of toxic metal oxides and polyhalogenated aromatic hydrocarbons produced during incineration and linked to human health risks.
Aim 2 will utilize the attomole (i.e. 10-18) sensitivity of AMS to improve the analyses of risks to human health due to hazardous chemicals in the environment. Chemicals labeled with low levels of 14C, 36Cl, and other long-lived isotopes will be traced quantitatively through ecosystems, animal models, and humans. Using HPLC separation the kinetics, the transformations and final biological targets of these chemicals including proteins and DNA will be identified. AMS will also be used to enhance the sensitivity of developed immunochemical biomarker detection. Nuclear Microprobe analyses will also be used to quantify the location, distribution, and amount of heavy metals from the environment of filters or tissue that can similarly lead to diseased states.
Aim 3 will address the questions of protein identify and modification associated with hazardous chemical exposure. HPLC/MS/MS, enzymatic digestion and peptide mapping will be the primary tools for the accomplishment of this aim. The Core scientists will educate Superfund research scientists in the use And value of the full array of analytical techniques.

Project Start
2000-04-01
Project End
2001-03-31
Budget Start
Budget End
Support Year
14
Fiscal Year
2000
Total Cost
$165,230
Indirect Cost
Name
University of California Davis
Department
Type
DUNS #
094878337
City
Davis
State
CA
Country
United States
Zip Code
95618
Ren, Qian; Ma, Min; Yang, Jun et al. (2018) Soluble epoxide hydrolase plays a key role in the pathogenesis of Parkinson's disease. Proc Natl Acad Sci U S A 115:E5815-E5823
Pecic, Stevan; Zeki, Amir A; Xu, Xiaoming et al. (2018) Novel piperidine-derived amide sEH inhibitors as mediators of lipid metabolism with improved stability. Prostaglandins Other Lipid Mediat 136:90-95
Yamanashi, Haruto; Boeglin, William E; Morisseau, Christophe et al. (2018) Catalytic activities of mammalian epoxide hydrolases with cis and trans fatty acid epoxides relevant to skin barrier function. J Lipid Res 59:684-695
Wang, Fuli; Zhang, Hongyong; Ma, Ai-Hong et al. (2018) COX-2/sEH Dual Inhibitor PTUPB Potentiates the Antitumor Efficacy of Cisplatin. Mol Cancer Ther 17:474-483
Napimoga, M H; Rocha, E P; Trindade-da-Silva, C A et al. (2018) Soluble epoxide hydrolase inhibitor promotes immunomodulation to inhibit bone resorption. J Periodontal Res 53:743-749
Blöcher, René; Wagner, Karen M; Gopireddy, Raghavender R et al. (2018) Orally Available Soluble Epoxide Hydrolase/Phosphodiesterase 4 Dual Inhibitor Treats Inflammatory Pain. J Med Chem 61:3541-3550
Hao, Lei; Kearns, Jamie; Scott, Sheyenne et al. (2018) Indomethacin Enhances Brown Fat Activity. J Pharmacol Exp Ther 365:467-475
Yang, Yang-Ming; Sun, Dong; Kandhi, Sharath et al. (2018) Estrogen-dependent epigenetic regulation of soluble epoxide hydrolase via DNA methylation. Proc Natl Acad Sci U S A 115:613-618
Zheng, Jing; Chen, Juan; Zou, Xiaohan et al. (2018) Saikosaponin d causes apoptotic death of cultured neocortical neurons by increasing membrane permeability and elevating intracellular Ca2+ concentration. Neurotoxicology 70:112-121
Cui, Xiping; Vasylieva, Natalia; Shen, Ding et al. (2018) Biotinylated single-chain variable fragment-based enzyme-linked immunosorbent assay for glycocholic acid. Analyst 143:2057-2065

Showing the most recent 10 out of 1149 publications